Literature DB >> 3196092

Ulcerative colitis. Colorectal cancer risk in an unselected population.

J N Rutegård1, L R Ahsgren, K G Janunger.   

Abstract

One hundred twenty-seven patients were studied, representing the unselected population of patients with ulcerative colitis from a defined catchment area of about 70,000 inhabitants during 1961-1983. Seventy-seven patients had total colitis, and 50 patients had left-sided colitis. No prophylactic colectomy was performed. Despite this and a comprehensive follow-up of patients with long-standing, extensive colitis, primary colorectal carcinomas were diagnosed in only three patients, all of whom had total colitis. This was significantly (p less than 0.001) more than the expected number of patients with colorectal cancer in this subgroup, namely, 0.13. There were no deaths in colorectal carcinoma. Factors determining completeness of inclusion are discussed, and it is concluded that, in an unselected series of patients with ulcerative colitis, close cancer surveillance is indicated, although prophylactic surgery does not seem to be generally warranted.

Entities:  

Mesh:

Year:  1988        PMID: 3196092      PMCID: PMC1493844          DOI: 10.1097/00000658-198812000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  THE CANCER RISK IN ULCERATIVE COLITIS.

Authors:  I P MACDOUGALL
Journal:  Lancet       Date:  1964-09-26       Impact factor: 79.321

2.  The development of carcinoma of the large intestine in ulcerative colitis.

Authors:  I M DAWSON; J PRYSE-DAVIES
Journal:  Br J Surg       Date:  1959-09       Impact factor: 6.939

3.  Course and prognosis of ulcerative colitis: Part IV Carcinoma of the colon.

Authors: 
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

4.  Compliance, cost, and common sense limit cancer control in colitis.

Authors:  J E Lennard-Jones
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

5.  Ulcerative colitis in the Jewish population of Tel-Aviv Uafo. II: The rarity of malignant degeneration.

Authors:  T Gilat; Z Zemishlany; J Ribak; Y Bennaroya; P Lilos
Journal:  Gastroenterology       Date:  1974-11       Impact factor: 22.682

6.  New surgical approaches to ulcerative colitis in children and adults.

Authors:  A G Coran
Journal:  World J Surg       Date:  1985-04       Impact factor: 3.352

7.  A radiological and pathological correlation of the mucosal changes in ulcerative colitis.

Authors:  C I Bartram; K Walmsley
Journal:  Clin Radiol       Date:  1978-05       Impact factor: 2.350

8.  Ulcerative colitis. Mortality and surgery in an unselected population.

Authors:  J Rutegård; L Ahsgren; K G Janunger
Journal:  Acta Chir Scand       Date:  1988-03

9.  Cancer in universal and left-sided ulcerative colitis: factors determining risk.

Authors:  A J Greenstein; D B Sachar; H Smith; A Pucillo; A E Papatestas; I Kreel; S A Geller; H D Janowitz; A H Aufses
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

10.  Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study.

Authors:  O Broström; R Löfberg; A Ost; H Reichard
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

View more
  4 in total

1.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

2.  Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder.

Authors:  Gopal Nath; Anil K Gulati; Vijay K Shukla
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

Review 3.  Inflammatory Bowel Disease-related Colorectal Cancer in the Asia-Pacific Region: Past, Present, and Future.

Authors:  Wong Zhiqin; Shanthi Palaniappan; Raja Affendi Raja Ali
Journal:  Intest Res       Date:  2014-07-25

4.  Genomic instability in liver cells caused by an LPS-induced bystander-like effect.

Authors:  Igor Kovalchuk; Paul Walz; James Thomas; Olga Kovalchuk
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.